The most striking valuation signal is the 184.4x P/S multiple, which implies the market expects sales to surge at an annualized rate of >50% over the next three years—a growth trajectory that would justify the premium only if capacity expansion and contract wins materialize on schedule.
The primary risk is that sales may not accelerate as the market assumes; a shortfall of even 20% in projected revenue would collapse the P/S multiple from 184.4x to roughly 147x, still high but materially reducing the upside and potentially triggering a re‑rating toward 'overvalued'.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | N/A (10Y CAGR) | Analyst Rev × N/A margin |
| PV of FCF | N/A | N/A |
| Terminal Value (PV) | N/A | N/A |
| Enterprise Value | N/A | N/A |
| Equity Value | N/A | N/A |
| Implied Stock Price | N/A | N/A |
| Upside/Downside | N/A | N/A |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/B (Peer) | $0.75 | -94.6% | Peer median P/B (1.80x) × Book Value per Share |
| P/S (Peer) | $0.09 | -99.3% | Peer median P/S (1.21x) × Revenue per Share |
| Analyst Target | $15.38 | +10.3% | Consensus of 4 analysts |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net